Enrolling in a clinical trial starts with finding a study that matches your condition, confirming you meet its eligibility requirements, and completing a screening process. Most people can search for open trials on their own using free public databases, though your doctor can also refer you directly. The process from first search to actual enrollment typically takes a few weeks, depending on the trial’s screening requirements.
Finding Trials That Match Your Situation
ClinicalTrials.gov is the largest public database of studies and the best starting point for anyone in the United States. The site lets you search by condition or disease, specific treatment, and location (city, state, zip code, or country). A “Focus Your Search” menu lets you filter results by study status, so you can narrow your list to trials currently marked as “Recruiting” or “Enrolling by Invitation” and skip the ones that have already closed.
You’ll see three main types of studies in search results: interventional studies (the classic clinical trial testing a treatment), observational studies (where researchers track outcomes without assigning a treatment), and expanded access programs (which give seriously ill patients access to experimental therapies outside a formal trial). Most people searching for enrollment are looking for interventional studies.
If you’re outside the United States, the World Health Organization maintains the International Clinical Trials Registry Platform at trialsearch.who.int. It pulls from a network of national registries around the world, making it useful for finding studies in your country. Many large trials also recruit across multiple countries, so both databases are worth checking.
Your own doctor or specialist is another valuable route. Physicians who treat specific conditions often know which trials are actively recruiting in their area, and some trials only accept participants through physician referral.
Understanding Eligibility Criteria
Every trial lists two sets of requirements: inclusion criteria (what you need to qualify) and exclusion criteria (what would disqualify you). Inclusion criteria typically specify a particular disease, a minimum severity or stage, and sometimes a specific age range or biological marker. Exclusion criteria are designed to screen out factors that could complicate results or put you at risk, such as other chronic conditions, certain medications you’re currently taking, or recent surgeries.
These criteria exist for scientific and safety reasons, but they can sometimes feel arbitrary. An FDA workshop found that about 27% of trials for diseases common in older adults excluded participants based on age alone, even though the agency considers age-only exclusions rarely appropriate. Older adults are also more likely to be screened out indirectly because they tend to have multiple chronic conditions or take several prescription medications, both common exclusion factors.
Don’t assume you’re ineligible just from reading the listing. Criteria descriptions online can be technical, and the research team can clarify whether your specific situation fits. It’s always worth making the call.
What Happens During Screening
Once you contact a trial’s research team (usually through a phone number or online form on the listing page), the first step is a pre-screening conversation. A coordinator will ask basic questions about your health history to see if you’re a potential match. If you seem like a fit, you’ll be invited for a screening visit.
The screening visit is more thorough. It may include blood work, imaging, physical exams, or other tests specific to the study. The purpose is to verify that you meet all the inclusion criteria and none of the exclusion criteria. Some trials complete screening in a single visit; others require multiple appointments over a few weeks. Not everyone who screens will qualify. This is normal and not a reflection of your health in general.
The Informed Consent Process
Before you officially enroll, you’ll go through informed consent. This is both a conversation and a document. Federal regulations require the research team to explain several things clearly: the purpose of the study, all reasonably foreseeable risks and discomforts, any potential benefits, what the study procedures involve, and how long participation will last. The description of risks cannot downplay the probability or severity of side effects.
One of the most important protections built into consent: your participation is entirely voluntary. You can decline to join without any penalty, and you can withdraw at any time for any reason without losing access to benefits or medical care you’re otherwise entitled to. No consent form is allowed to include language that limits your right to leave. If the study protocol changes in a way that might affect your willingness to continue, the team is required to inform you.
Signing the consent form is the point at which you’re considered enrolled. Take your time reading it. Ask questions. You can take the document home before signing if you need time to think.
Know the Trial Phase Before You Join
Clinical trials progress through distinct phases, and the phase tells you a lot about what to expect.
- Phase I involves fewer than 50 participants, often healthy volunteers. The goal is to establish a safe dose range and understand how the body processes the treatment. These studies can last from one week to several months.
- Phase II enrolls roughly 5 to 100 patients with the target condition. Researchers are testing whether the treatment works at specific doses, looking at effectiveness and side effects.
- Phase III is the large-scale confirmation stage, recruiting 300 to 3,000 or more patients across multiple sites. The treatment is compared against a placebo or the current standard therapy. This is the phase that typically supports approval by regulatory agencies.
- Phase IV happens after a treatment is already approved and on the market. These studies track long-term safety and real-world effectiveness over extended periods.
Earlier phases carry more uncertainty about both risks and benefits. Later phases offer more data on safety but may involve randomization, meaning you could be assigned to a control group receiving standard treatment or a placebo rather than the experimental therapy.
Costs, Insurance, and Compensation
The experimental treatment itself is almost always provided at no cost by the study sponsor. However, routine medical care you receive during the trial, such as doctor visits, lab tests, and imaging that would be part of standard treatment, may be billed to your insurance.
Medicare has a specific policy covering routine care costs during qualifying clinical trials. Medicare will pay for items and services that would normally be covered outside the trial, including care in both the experimental and control groups. What Medicare won’t cover: the investigational treatment itself (unless it would be covered outside the trial), tests done purely for data collection rather than your direct care, and items the sponsor customarily provides free to all participants. Private insurers vary, so checking with your plan before enrolling is worth the effort.
Many trials compensate participants for their time and inconvenience. The FDA considers this an acceptable practice. Reimbursement for travel, parking, airfare, and lodging is standard and separate from participation payments. The FDA specifically notes that travel reimbursement does not raise concerns about pressuring people to join. Ask the research coordinator up front what expenses are covered and whether you’ll receive any payment for your time.
How Your Safety Is Protected
Every clinical trial involving human participants must be reviewed and approved by an Institutional Review Board (IRB) before it can begin recruiting. The IRB is an independent committee that evaluates the study design, the consent process, and the risk-to-benefit ratio. It has the authority to approve, require changes to, or reject a study entirely.
The IRB’s oversight doesn’t end at approval. Any changes to the study protocol must receive IRB approval before being implemented, unless the change is an immediate fix to protect participants from a newly identified hazard. The board also requires prompt reporting of any problems or unexpected events that arise during the trial.
Questions Worth Asking Before You Decide
The National Cancer Institute maintains a list of questions designed for prospective trial participants, and they apply well beyond cancer studies. The most useful ones to bring to your conversation with the research team:
- About the trial itself: What is the purpose? How long will I be in the study? How many visits are required, and how far will I need to travel? What tests and procedures are involved? How will I learn the results?
- About risks and benefits: What are the possible side effects? How do the risks compare to standard treatment? What are the potential benefits, and why might this treatment not be better than what’s currently available?
- About daily life: How will this affect my routine? Will I need to stay in the hospital at any point? Will there be follow-up visits after the trial ends?
- About costs and logistics: Which costs will I be responsible for? What will insurance cover? Who can help me navigate billing questions?
- About your rights: How is my health information kept private? What are my options if I decide to leave the trial? Who is in charge of my care during the study?
You don’t need to decide on the spot. Ask how long you have to make up your mind, and take that time. A good research team will welcome your questions and give you space to choose without pressure.